Adam Benjamin Weiner

Title(s)HS Clinical Instructor, Urology
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature. Eur Urol Oncol. 2022 08; 5(4):377-387. Weiner AB, Siebert AL, Fenton SE, Abida W, Agarwal N, Davis ID, Dorff TB, Gleave M, James ND, Poon DMC, Suzuki H, Sweeney CJ. PMID: 35641398.
      View in: PubMed   Mentions:    Fields:    
    2. High intratumoral plasma cells content in primary prostate cancer defines a subset of tumors with potential susceptibility to immune-based treatments. Prostate Cancer Prostatic Dis. 2022 May 14. Weiner AB, Yu CY, Kini M, Liu Y, Davicioni E, Mitrofanova A, Lotan TL, Schaeffer EM. PMID: 35568781.
      View in: PubMed   Mentions:    Fields:    
    3. Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer. Cancer. 2022 06 15; 128(12):2269-2280. Mendes AA, Lu J, Kaur HB, Zheng SL, Xu J, Hicks J, Weiner AB, Schaeffer EM, Ross AE, Balk SP, Taplin ME, Lack NA, Tekoglu E, Maynard JP, De Marzo AM, Antonarakis ES, Sfanos KS, Joshu CE, Shenderov E, Lotan TL. PMID: 35333400; PMCID: PMC9133095.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Correction: Inflammatory bowel disease induces inflammatory and preneoplastic changes in the prostate. Prostate Cancer Prostatic Dis. 2022 Feb; 25(2):375. Desai AS, Sagar V, Lysy B, Weiner AB, Ko OS, Driscoll C, Rodriguez Y, Vatapalli R, Unno K, Han H, Cohen JE, Vo AX, Pham M, Shin M, Jain-Poster K, Ross J, Morency EG, Meyers TJ, Witte JS, Wu J, Abdulkadir SA, Kundu SD. PMID: 34158596.
      View in: PubMed   Mentions:    Fields:    
    5. A transcriptomic model for homologous recombination deficiency in prostate cancer. Prostate Cancer Prostatic Dis. 2021 Jul 05. Weiner AB, Liu Y, McFarlane M, Bawa PS, Li EV, Zhao X, Li Z, Hammoud T, Hazime M, Karnes RJ, Davicioni E, Reichert ZR, Chinnaiyan AM, Lotan TL, Spratt DE, Schaeffer EM. PMID: 34226663.
      View in: PubMed   Mentions: 1     Fields:    
    6. It's all in the name: Does nomenclature for indolent prostate cancer impact management and anxiety? Cancer. 2021 09 15; 127(18):3354-3360. Hudnall MT, Desai AS, Tsai KP, Weiner AB, Vo AX, Ko OS, Jan S, Schaeffer EM, Kundu SD. PMID: 34081322; PMCID: PMC8722476.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Inflammatory bowel disease induces inflammatory and pre-neoplastic changes in the prostate. Prostate Cancer Prostatic Dis. 2022 09; 25(3):463-471. Desai AS, Sagar V, Lysy B, Weiner AB, Ko OS, Driscoll C, Rodriguez Y, Vatapalli R, Unno K, Han H, Cohen JE, Vo AX, Pham M, Shin M, Jain-Poster K, Ross J, Morency EG, Meyers TJ, Witte JS, Wu J, Abdulkadir SA, Kundu SD. PMID: 34035460; PMCID: PMC8647933.
      View in: PubMed   Mentions: 1     Fields:    
    8. Cause of death during prostate cancer survivorship: A contemporary, US population-based analysis. Cancer. 2021 08 15; 127(16):2895-2904. Weiner AB, Li EV, Desai AS, Press DJ, Schaeffer EM. PMID: 33882145.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. A PRC2-independent function for EZH2 in regulating rRNA 2'-O methylation and IRES-dependent translation. Nat Cell Biol. 2021 04; 23(4):341-354. Yi Y, Li Y, Meng Q, Li Q, Li F, Lu B, Shen J, Fazli L, Zhao D, Li C, Jiang W, Wang R, Liu Q, Szczepanski A, Li Q, Qin W, Weiner AB, Lotan TL, Ji Z, Kalantry S, Wang L, Schaeffer EM, Niu H, Dong X, Zhao W, Chen K, Cao Q. PMID: 33795875; PMCID: PMC8162121.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    10. Efficacy and Adverse Events of Docetaxel for Metastatic, Hormone-sensitive Prostate Cancer Among Elderly Men: A Post Hoc Analysis of the CHAARTED Trial. Clin Genitourin Cancer. 2021 10; 19(5):388-395. Li EV, Siddiqui MR, Weiner AB, Prizment AE, Ryan CJ, Morgans AK. PMID: 33906801.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    11. Editorial Comment. J Urol. 2021 05; 205(5):1284-1285. Weiner AB, Kundu SD. PMID: 33705232.
      View in: PubMed   Mentions:    Fields:    
    12. Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes. Nat Commun. 2021 02 10; 12(1):935. Weiner AB, Vidotto T, Liu Y, Mendes AA, Salles DC, Faisal FA, Murali S, McFarlane M, Imada EL, Zhao X, Li Z, Davicioni E, Marchionni L, Chinnaiyan AM, Freedland SJ, Spratt DE, Wu JD, Lotan TL, Schaeffer EM. PMID: 33568675; PMCID: PMC7876147.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    13. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer. Eur Urol. 2021 03; 79(3):374-383. Jairath NK, Dal Pra A, Vince R, Dess RT, Jackson WC, Tosoian JJ, McBride SM, Zhao SG, Berlin A, Mahal BA, Kishan AU, Den RB, Freedland SJ, Salami SS, Kaffenberger SD, Pollack A, Tran P, Mehra R, Morgan TM, Weiner AB, Mohamad O, Carroll PR, Cooperberg MR, Karnes RJ, Nguyen PL, Michalski JM, Tward JD, Feng FY, Schaeffer EM, Spratt DE. PMID: 33293078.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    14. Surgical versus Medical Castration for Metastatic Prostate Cancer: Use and Overall Survival in a National Cohort. J Urol. 2020 05; 203(5):933-939. Weiner AB, Cohen JE, DeLancey JO, Schaeffer EM, Auffenberg GB. PMID: 31746656; PMCID: PMC7145732.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    15. Insurance coverage, stage at diagnosis, and time to treatment following dependent coverage and Medicaid expansion for men with testicular cancer. PLoS One. 2020; 15(9):e0238813. Weiner AB, Jan S, Jain-Poster K, Ko OS, Desai AS, Kundu SD. PMID: 32936794; PMCID: PMC7494102.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. Survival following upfront chemotherapy for treatment-naïve metastatic prostate cancer: a real-world retrospective cohort study. Prostate Cancer Prostatic Dis. 2021 03; 24(1):261-267. Weiner AB, Ko OS, Li EV, Vo AX, Desai AS, Breen KJ, Nadler RB, Morgans AK. PMID: 32873919.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Predictors of use and overall survival for patients undergoing metastasectomy for bladder cancer in a national cohort. Int J Urol. 2020 09; 27(9):736-741. Weiner AB, Pham MN, Isaacson DS, Ko OS, Breen KJ, Nadler RB. PMID: 32588523.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes. J Clin Med. 2020 Jun 24; 9(6). Jairath NK, Farha MW, Srinivasan S, Jairath R, Green MD, Dess RT, Jackson WC, Weiner AB, Schaeffer EM, Zhao SG, Feng FY, El Naqa I, Spratt DE. PMID: 32599760; PMCID: PMC7356642.
      View in: PubMed   Mentions: 6  
    19. Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy. Eur Urol Oncol. 2021 12; 4(6):955-962. Weiner AB, Faisal FA, Davicioni E, Karnes RJ, Griend DJV, Lotan TL, Schaeffer EM. PMID: 32540218; PMCID: PMC7736205.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study. Int J Cancer. 2020 11 15; 147(10):2735-2742. Meyers TJ, Weiner AB, Graff RE, Desai AS, Cooley LF, Catalona WJ, Hanauer SB, Wu JD, Schaeffer EM, Abdulkadir SA, Kundu SD, Witte JS. PMID: 32399975; PMCID: PMC7577830.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    21. Risk Assessment and Considerations for Proper Management of Elderly Men with Advanced Prostate Cancer: A Systematic Review. Eur Urol Oncol. 2020 08; 3(4):400-409. Shevach JW, Weiner AB, Kasimer RN, Miller CH, Morgans AK. PMID: 32471792.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Changes in prostate-specific antigen at the time of prostate cancer diagnosis after Medicaid expansion in young men. Cancer. 2020 07 15; 126(14):3229-3236. Weiner AB, Vo AX, Desai AS, Hu JC, Spratt DE, Schaeffer EM. PMID: 32343403.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    23. Medicaid Expansion Did not Improve Time to Treatment for Young Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2020 08; 18(4):e386-e390. Desai AS, Pham M, Weiner AB, Siddiqui MR, Driscoll C, Jain-Poster K, Ko OS, Vo A, Kundu SD. PMID: 32280026.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Willingness to Participate in Home Screening for Urologic Cancers in the General Population: An Online Survey of Over 1400 Adults. Urology. 2020 Feb; 136:35-40. Tsai KP, Hudnall MT, Weiner AB, Keeter MK, Meeks JJ. PMID: 31790787.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Editorial Comment. J Urol. 2020 02; 203(2):290-291. Weiner AB, Kundu SD. PMID: 31738121.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer. Clin Cancer Res. 2019 11 15; 25(22):6721-6730. Spratt DE, Alshalalfa M, Fishbane N, Weiner AB, Mehra R, Mahal BA, Lehrer J, Liu Y, Zhao SG, Speers C, Morgan TM, Dicker AP, Freedland SJ, Karnes RJ, Weinmann S, Davicioni E, Ross AE, Den RB, Nguyen PL, Feng FY, Lotan TL, Chinnaiyan AM, Schaeffer EM. PMID: 31515456; PMCID: PMC6858964.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    27. Editorial Comment. J Urol. 2019 10; 202(4):747. Weiner AB. PMID: 31242050.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Quality of Life-Focused Decision-Making for Prostate Cancer. Curr Urol Rep. 2019 Aug 29; 20(10):57. Shevach J, Weiner A, Morgans AK. PMID: 31468212.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    29. Corrigendum to: National practice patterns for lymph node irradiation in 197,000 men receiving external beam radiotherapy for localized prostate cancer. Urol Oncol. 2019 Aug; 37(8):563. Weiner AB, Ko OS, Zhu A, Spratt DE, Hu JC, Schaeffer EM. PMID: 31351589.
      View in: PubMed   Mentions:    Fields:    
    30. Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment Paradigm. Curr Treat Options Oncol. 2019 07 09; 20(9):69. Weiner AB, Nettey OS, Morgans AK. PMID: 31286275.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. Reply to Zeynep G. Gul, Alberto Martini, and Carl A. Olsson's Letter to the Editor re: Jacob A. Burns, Adam B. Weiner, William J. Catalona, et al. Inflammatory Bowel Disease and the Risk of Prostate Cancer. Eur Urol 2019;75:846-52. Eur Urol. 2019 10; 76(4):e99-e100. Burns JA, Weiner AB, Kundu S. PMID: 31151679.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Contemporary Comparison of Open to Robotic Prostatectomy at a Veteran's Affairs Hospital. Mil Med. 2019 05 01; 184(5-6):e330-e337. Desai A, Hudnall M, Weiner AB, Patel M, Cohen J, Gogana P, Sharifi R, Meeks JJ. PMID: 30535336.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. National practice patterns for lymph node irradiation in 197,000 men receiving external beam radiotherapy for localized prostate cancer. Urol Oncol. 2019 06; 37(6):353.e1-353.e8. Weiner AB, Ko OS, Zhu A, Spratt DE, Hu JC, Schaeffer EM. PMID: 30611643; PMCID: PMC6511330.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Inflammatory Bowel Disease and the Risk of Prostate Cancer. Eur Urol. 2019 05; 75(5):846-852. Burns JA, Weiner AB, Catalona WJ, Li EV, Schaeffer EM, Hanauer SB, Strong S, Burns J, Hussain MHA, Kundu SD. PMID: 30528221; PMCID: PMC6542355.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    35. n = 1. Acad Med. 2018 12; 93(12):1820. Weiner AB. PMID: 30489310.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. "Real-world" Practice Makes Perfect: Ensuring the Active Component of Active Surveillance for Prostate Cancer. Eur Urol. 2018 12; 74(6):708-709. Weiner AB, Schaeffer EM, Eggener SE. PMID: 30224197.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study. Eur Urol Oncol. 2019 05; 2(3):304-310. Weiner AB, Desai AS, Meeks JJ. PMID: 31200845.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    38. Editorial Comment. J Urol. 2018 11; 200(5):994-995. Weiner AB. PMID: 30059668.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. The Influence of Decision Aids on Prostate Cancer Screening Preferences: A Randomized Survey Study. J Urol. 2018 11; 200(5):1048-1055. Weiner AB, Tsai KP, Keeter MK, Victorson DE, Schaeffer EM, Catalona WJ, Kundu SD. PMID: 29852180; PMCID: PMC6203648.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    40. Rates and Predictors of Conversion to Open Surgery During Minimally Invasive Radical Cystectomy. J Endourol. 2018 06; 32(6):488-494. Ko OS, Weiner AB, Smith ND, Meeks JJ. PMID: 29620960.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Robotic-Assisted vs Laparoscopic Radical Nephrectomy. JAMA. 2018 03 20; 319(11):1165. Weiner AB, Matulewicz RS, Meeks JJ. PMID: 29558547.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013). Urol Oncol. 2018 May; 36(5):237.e9-237.e17. Weiner AB, Keeter MK, Manjunath A, Meeks JJ. PMID: 29338913.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    43. Oncologic outcomes in patients with nonurothelial bladder cancer. Indian J Urol. 2018 Jan-Mar; 34(1):39-44. Patel SG, Weiner AB, Keegan K, Morgan T. PMID: 29343911; PMCID: PMC5769248.
      View in: PubMed   Mentions: 6  
    44. Prostate Cancer: A Contemporary Approach to Treatment and Outcomes. Med Clin North Am. 2018 Mar; 102(2):215-229. Weiner AB, Kundu SD. PMID: 29406054.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    45. Radiographic hemithorax white-out following percutaneous nephrolithotomy. Urol Case Rep. 2018 Mar; 17:1-3. Zhu A, Weiner AB, Nadler RB. PMID: 29541579; PMCID: PMC5849941.
      View in: PubMed   Mentions:
    46. Active Surveillance for Prostate Cancer. JAMA. 2017 12 05; 318(21):2152. Matulewicz RS, Weiner AB, Schaeffer EM. PMID: 29209723.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    47. Contemporary management of men with high-risk localized prostate cancer in the United States. Prostate Cancer Prostatic Dis. 2017 12; 20(4):442. Weiner AB, Matulewicz RS, Schaeffer EM, Liauw SL, Feinglass JM, Eggener SE. PMID: 29125150.
      View in: PubMed   Mentions: 3     Fields:    
    48. The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004-2013). Urol Oncol. 2018 03; 36(3):91.e1-91.e6. Weiner AB, Matulewicz RS, Tosoian JJ, Feinglass JM, Schaeffer EM. PMID: 29153624; PMCID: PMC6048442.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    49. Contemporary management of men with high-risk localized prostate cancer in the United States. Prostate Cancer Prostatic Dis. 2017 09; 20(3):283-288. Weiner AB, Matulewicz RS, Schaeffer EM, Liauw SL, Feinglass JM, Eggener SE. PMID: 28631720.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    50. Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases. Urol Oncol. 2017 01; 35(1):31.e1-31.e6. Wenger H, Weiner AB, Razmaria A, Paner GP, Eggener SE. PMID: 27692833.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    51. Management trends for men with early-stage nonseminomatous germ cell tumors of the testicle: An analysis of the National Cancer Database. Cancer. 2017 01 01; 123(2):245-252. Weiner AB, Pearce SM, Eggener SE. PMID: 27626903.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    52. Increasing incidence of metastatic prostate cancer in the United States (2004-2013). Prostate Cancer Prostatic Dis. 2016 12; 19(4):395-397. Weiner AB, Matulewicz RS, Eggener SE, Schaeffer EM. PMID: 27431496.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    53. National Economic Conditions and Patient Insurance Status Predict Prostate Cancer Diagnosis Rates and Management Decisions. J Urol. 2016 May; 195(5):1383-1389. Weiner AB, Conti RM, Eggener SE. PMID: 26707507.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    54. Bladder Cancer Mortality in the United States: A Geographic and Temporal Analysis of Socioeconomic and Environmental Factors. J Urol. 2016 Feb; 195(2):290-6. Smith ND, Prasad SM, Patel AR, Weiner AB, Pariser JJ, Razmaria A, Maene C, Schuble T, Pierce B, Steinberg GD. PMID: 26235377.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    55. Radical Cystectomy with Ileal Conduit Urinary Diversion in a Patient with a Left Ventricular Assist Device. Case Rep Urol. 2015; 2015:484679. Pariser JJ, Weiner AB, Steinberg GD. PMID: 26290767; PMCID: PMC4531180.
      View in: PubMed   Mentions:
    56. Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate. Urology. 2015 Oct; 86(4):777-82. Packiam VT, Patel SG, Pariser JJ, Richards KA, Weiner AB, Paner GP, VanderWeele DJ, Zagaja GP, Eggener SE. PMID: 26196240.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    57. Intravesical therapy for bladder cancer. Expert Opin Pharmacother. 2015 Apr; 16(6):889-901. Patel SG, Cohen A, Weiner AB, Steinberg GD. PMID: 25773220.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    58. Photochemistry. Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure. Science. 2015 Feb 20; 347(6224):842-7. Premi S, Wallisch S, Mano CM, Weiner AB, Bacchiocchi A, Wakamatsu K, Bechara EJ, Halaban R, Douki T, Brash DE. PMID: 25700512; PMCID: PMC4432913.
      View in: PubMed   Mentions: 131     Fields:    Translation:HumansAnimalsCells
    59. Population based analysis of incidence and predictors of open conversion during minimally invasive radical prostatectomy. J Urol. 2015 Mar; 193(3):826-31. Weiner AB, Murthy P, Richards KA, Patel SG, Eggener SE. PMID: 25632850.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    60. Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States. Urol Oncol. 2015 Apr; 33(4):164.e11-7. Weiner AB, Patel SG, Eggener SE. PMID: 25624093.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    61. National trends in the management of low and intermediate risk prostate cancer in the United States. J Urol. 2015 Jan; 193(1):95-102. Weiner AB, Patel SG, Etzioni R, Eggener SE. PMID: 25106900.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    62. Metastatic small cell carcinoma of the prostate: Population-based analysis of patient characteristics and treatment paradigms. Urol Oncol. 2015 Feb; 33(2):70.e1-7. Cohen A, Richards KA, Patel S, Weiner A, Eggener SE, Szmulewitz RZ. PMID: 25044254.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    63. Population-based analysis of treatment modalities and survival for clinically localized small-cell carcinoma of the prostate. Prostate Cancer Prostatic Dis. 2014 Sep; 17(3):286-91. Weiner AB, Patel SG, Richards KA, Szmulewitz RZ, Eggener SE. PMID: 25027862.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    64. Ongoing Gleason grade migration in localized prostate cancer and implications for use of active surveillance. Eur Urol. 2014 Oct; 66(4):611-2. Weiner AB, Etzioni R, Eggener SE. PMID: 24630416; PMCID: PMC4155020.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    65. Dural metastases in advanced prostate cancer: a case report and review of the literature. Curr Urol. 2013 Feb; 7(3):166-8. Weiner AB, Cortes-Mateus S, De Luis E, Durán I. PMID: 24917781; PMCID: PMC4025047.
      View in: PubMed   Mentions: 3  
    Adam's Networks
    Concepts (205)
    Derived automatically from this person's publications.
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _